Skip to content

CHIROPRACTIE WAREGEM

Active
Private limited company (pre-2019)founded 200916 yrs activeLeenakkerstraat 28, 8791 Waregem, BelgiumKBO/BCE: BE 0819.611.693
Summary

CHIROPRACTIE WAREGEM has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €397,608 and a net result of €94,469. Equity is growing by ~24.9% per year across the filed fiscal years. Its solvency ranks better than 24% of 18230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

What they do
General medical practice
NACE 86210
1 site
How big
€1.4mtotal assets 2025
Staff
2 FTE
Equity
€397,608
Profit
€94,469
Turnover not published (abridged schema)
Financially healthy?
92 Excellent Checked score 2025
Bankruptcy chance 12 m
0.1%
Who decides
Accounts on time
Why 92- Figures for FY 2025 (filed 05-11-2025)+ Size: total assets €1.4m+ Sector Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Better than 38% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 54+6
equity 28.6% of total assets
Liquidity 58+6
short-term debt 15.8% · cash 9.3%
Profitability 77+2
return on assets 6.8%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (23,595 companies)
  • Size: total assets €1.4m lowers the probability for this profile
  • Sector Human health activities (NACE 86) lowers the probability
  • Figures for FY 2025 (filed 05-11-2025) raises the probability
Credit up to €35,000 at 30 days acceptable
Liquidity short (current ratio 0.64 against 0.33 in 2024; short-term debt: 15.8% and cash: 9.3% of total assets), and 71.4% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 25%, liquidity 34%, profitability 22%, growth against the median 72%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610020317, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €1.4m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
raises risk · Figures for FY 2025 (filed 05-11-2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 18230 sector peers (2025).
NBB · sector comparison
Position among 18230 sector peers
Solvency
better than 24%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 31-10-2025, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
on the day
2023
30 d late
2022
115 d late
2021
4 d late
2020
13 d late
2019
8 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 24 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 4 November (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
31-03-2026 close02-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Highest result since 2019net €94,469 ▲48.5%
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: 7 profitable years in a rowprofit 2025: €94,469 7 years View
  • Among the largest 12% on gross marginsector median €113,839 · 18,233 companies €337,593 View
  • Positive: Equity rose in 2025from €303,139 to €397,608 ▲ 31.2% View

By topic

Financials

Fiscal year
2025
Total assets
€1.4m
Profit
€94,469
Solvency
28.6%
Total assets▲ 5.5%
Net result
20192025
Go to Financials

Timeline

Events
14
Since
2016
Next accounts
by 31-10-2026
  1. 31-10-2025Annual accounts filed
  2. 31-03-2025Highest result since 2019
  3. 31-10-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
General medical practiceNACE 86210
Founded
12-10-2009
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.